Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 232.0 | 61 | |
RA2159 | JNK-IN-11 | 0.3 | uM | 1 | GM-CSF | 318.0 | 70 | ||||
N2586 | EGF | 100 | ng/mL | 1 | GM-CSF | 230.0 | 73 | ||||
N2586 | PD184352 | 0.1 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 232.5 | 64 | |
N2586 | Lestaurtinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 250.5 | 50 | |
N2586 | Ruxolitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 285.0 | 49 | |
N2586 | Tofacitinib | 0.3 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 277.0 | 45 | |
N2586 | IKK16 | 2.0 | uM | EGF | 100 | ng/mL | 1 | GM-CSF | 248.0 | 31 | |
N2586 | JNK-IN-11 | 0.3 | uM | 1 | GM-CSF | 263.5 | 80 | ||||
RA2159 | IGF-I | 100 | ug/mL | 1 | GM-CSF | 256.0 | 63 | ||||
RA2159 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 197.0 | 61 | |
RA2159 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 276.0 | 63 | |
RA2159 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 251.0 | 58 | |
RA2159 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 257.0 | 97 | |
RA2159 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 227.0 | 61 | |
RA2159 | 1 | GM-CSF | 254.0 | 64 | |||||||
N2586 | IGF-I | 100 | ug/mL | 1 | GM-CSF | 235.0 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 225.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 253.5 | 70 | |
N2586 | Ruxolitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 212.0 | 40 | |
N2586 | Tofacitinib | 0.3 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 227.0 | 35 | |
N2586 | IKK16 | 2.0 | uM | IGF-I | 100 | ug/mL | 1 | GM-CSF | 217.0 | 64 | |
N2586 | 1 | GM-CSF | 283.0 | 71 | |||||||
RA2159 | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 97.0 | 72 | ||||
RA2159 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 136.0 | 62 |